Larson Financial Group’s 10x Genomics TXG Stock Holding History

Larson Financial Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$316K	Buy	8,231 +2,445	+42%	+$64.1K	0.01%	687
2026 Q1	$123K	Buy	5,786 +3,422	+145%	+$68.4K	﹤0.01%	905
2025 Q4	$38.6K	Buy	2,364 +1,470	+164%	+$22.2K	﹤0.01%	1375
2025 Q3	$10.5K	Buy	894 +780	+684%	+$10.2K	﹤0.01%	1995
2025 Q2	$1.32K	Sell	114 -41	-26%	-$374	﹤0.01%	2551
2025 Q1	$1.35K	Buy	+155	New	+$1.95K	﹤0.01%	2292
2024 Q4	–	Sell	-1,806	Closed	-$40.8K	–	2910
2024 Q3	$40.8K	Buy	1,806 +484	+37%	+$10K	﹤0.01%	967
2024 Q2	$25.7K	Sell	1,322 -5,632	-81%	-$147K	﹤0.01%	985
2024 Q1	$261K	Sell	6,954 -1,827	-21%	-$80.3K	0.02%	339
2023 Q4	$491K	Buy	8,781 +3	+0%	+$131	0.04%	224
2023 Q3	$362K	Buy	+8,778	New	+$457K	0.04%	231

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Larson Financial Group's TXG Position: Q2 2026 in Review

Larson Financial Group increased its 10x Genomics (TXG) stake by 42% in Q2 2026, buying an estimated $64.1K and bringing the position to 8,231 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #687.

Larson Financial Group first reported a position in TXG in Q3 2023 and has held it in 11 quarters since. The position peaked at $491K in Q4 2023. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Larson Financial Group held 8,231 shares of 10x Genomics worth $316K as of Q2 2026.
Larson Financial Group bought 2,445 10x Genomics shares in Q2 2026, an estimated $64.1K.
10x Genomics made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #687 holding.
Larson Financial Group first reported a position in 10x Genomics in Q3 2023 and has held it in 11 quarters since.
Larson Financial Group's 10x Genomics position peaked at $491K in Q4 2023.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.